STADA Arzneimittel AG
STADA Arzneimittel AG: Supervisory Board of STADA Arzneimittel AG elects Dr. Günter von Au as new Chairman
STADA Arzneimittel AG / Key word(s): Miscellaneous
Bad Vilbel, September 27, 2017 – At today’s constituent meeting, the Supervisory Board of STADA Arzneimittel AG elected Dr. Günter von Au as its new Chairman.
On September 26, 2017 the District Court of Frankfurt am Main appointed Jan-Nicolas Garbe, Benjamin Kunstler, Bruno Schick, Dr. Michael Siefke and Dr. Günter von Au as new members of the Supervisory Board with immediate effect after the former Chairman of the Supervisory Board along with four other members of the Supervisory Board had stepped down from their offices as of the end of September 25, 2017 (see the Company’s ad hoc release of August 25, 2017). Contact: Or visit us in the Internet at www.stada.com.
27-Sep-2017 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | STADA Arzneimittel AG |
Stadastraße 2-18 | |
61118 Bad Vilbel | |
Germany | |
Phone: | +49 (0)6101 603- 113 |
Fax: | +49 (0)6101 603- 506 |
E-mail: | communications@stada.de |
Internet: | www.stada.de |
ISIN: | DE0007251803, DE0007251845, |
WKN: | 725180, 725184, |
Indices: | MDAX |
Listed: | Regulated Market in Dusseldorf, Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
End of Announcement | DGAP News Service |